Skip to main content
CBIO
NASDAQ Life Sciences

Crescent Biopharma Closes $143.7M Offering, Full Overallotment Exercised

Tom Rudovsky · Reported by GlobeNewswire
More coverage: Biotech Stocks · Healthcare
Sentiment info
Neutral
Importance info
7
Price
$15.11
Mkt Cap
$416.612M
52W Low
$8.72
52W High
$27.41
52W Position info
73% above low
Off High info
45% below high
Rel. Volume info
2.5× avg
Market data snapshot near publication time

CBIO sits 73% above its 52-week low of $8.72 on elevated volume (2.5× avg).

Summary

Crescent Biopharma closed its public offering, raising approximately $143.7 million in gross proceeds after the underwriters fully exercised their option to purchase additional shares. The final deal included 9,387,896 ordinary shares at $14.50 each and pre-funded warrants for 525,897 shares at $14.499 each. This follows the July 14 launch and July 15 pricing of the offering, with the overallotment exercise adding about $18.8 million to the originally announced $125 million deal. The company, which had $171.6 million in cash at the end of Q2, now has a significantly strengthened balance sheet to fund its oncology pipeline, including the lead PD-1 x VEGF bispecific antibody program.

At the time of this announcement, CBIO was trading at $15.11 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $416.6M. The 52-week trading range was $8.72 to $27.41. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: GlobeNewswire.


Price Chart

Share this article

Copied!

CBIO - Latest Insights

CBIO
Nov 12, 2026, 4:15 PM EST
Source: Wiseek News
Importance Score:
7
Price at Filing: $14.37
Real-time Price: $14.15 info
Change: -$0.220 (-2%) info
Market Cap: $550.371M info
CBIO
Nov 12, 2026, 4:11 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $14.37
Real-time Price: $14.15 info
Change: -$0.220 (-2%) info
Market Cap: $550.371M info
CBIO
Oct 15, 2026, 4:26 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $12.47
Real-time Price: $14.15 info
Change: +$1.68 (+13%) info
Market Cap: $550.371M info
CBIO
Oct 05, 2026, 7:30 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $14.91
Real-time Price: $14.15 info
Change: -$0.760 (-5%) info
Market Cap: $550.371M info
CBIO
Jul 30, 2026, 9:25 AM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $14.77
Real-time Price: $14.15 info
Change: -$0.620 (-4%) info
Market Cap: $550.371M info